Why can a good company still be a bad secondary investment?

The transaction is not the company

Private-market conversations often collapse the question into company quality: is this a strong business? That is important, but it is only one layer of a secondary underwriting decision.

A great company bought at the wrong price can produce weak returns. A strong asset with insufficient information can make the range of outcomes impossible to price responsibly. A compelling business can be wrong for a mandate that cannot tolerate the duration or concentration.

Price must be read against risk, not against the last round

A headline discount can look attractive while still being inadequate. Mercer’s review of GP-led secondary transactions emphasizes that outcome depends on a holistic valuation assessment rather than discount to reference NAV alone. Business quality, comparable valuations, cash flows, leverage, fees, governance and exit route all interact.

The same logic applies to direct private-company secondaries: “20% below the last round” says little until the buyer understands what has changed since that round and what risks the discount is meant to absorb.

Information quality changes the asset you are effectively buying

Two investors can pay the same price and still be underwriting different things if their information sets are materially different. One may understand current revenue quality, customer concentration and liquidity constraints. Another may be relying on stale round data and a broad narrative.

That is why information sufficiency should be treated as an underwriting variable rather than a footnote.

SpaceX is a useful illustration of entry-point dependence

SpaceX’s June 2026 IPO priced Class A shares at $135, according to SEC filings. The public filing created an information set materially richer than many private secondary buyers would have had earlier. The underlying company did not suddenly become a different company on listing day; the decision context changed — price, available disclosure, liquidity and governance visibility all became more explicit.

That is why ClarityInvest treats its public SpaceX analysis as an example of decision-pressure methodology, not as a reconstruction of an earlier private secondary purchase.

The company can be exceptional and the transaction can still be wrong.